在瘤病原和治疗策略中的铜恒温和铜亡
Chenbin Bian1,2,3, Zhuangzhuang Zheng1,2,3, Jing Su1,2,3
1Jilin Provincial Key Laboratory of Radiation Oncology and Therapy, The First Hospital of Jilin University, Changchun, China.
Frontiers in pharmacology
|September 28, 2023
概括
铜铜 铜铜 铜铜
科学领域:
- 生物化学和分子生物学
- 癌症研究 癌症研究
- 细胞生物学 细胞生物学
背景情况:
- 铜是一种必要的微量营养素,对真核生物的发育和复制至关重要.
- 铜稳态中断与致癌有关,影响癌细胞增殖,血管生成和转移.
- 铜,一种明显的依赖铜的细胞死亡途径,需要在瘤学中进行进一步的研究.
研究的目的:
- 系统地审查癌症中铜代谢和铜的调节机制.
- 探索cuproptosis在恶性瘤中的临床意义.
- 评估向铜离子用于癌症治疗的治疗潜力.
主要方法:
- 对铜代谢和铜症的文献进行系统审查.
- 对参与铜诱导细胞死亡的信号通路的分析.
- 对抗癌症药物开发的铜离子体和化剂的评估.
主要成果:
- 铜在细胞过程中的双重作用 (有益/有害) 是至关重要的.
- 型亡代表了一种新的细胞死亡模式,具有潜在的抗癌影响.
- 铜离子体和化剂在调节癌症进展方面表现有前途.
结论:
- 了解铜的新陈代谢和cuproptosis为抗瘤药物发现提供了新的途径.
- 准铜平衡可能是改善癌症患者存活率的可行策略.
- 对铜在特定癌症中的作用进行进一步的研究有必要进行临床应用.
更多相关视频
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K


